Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-6.7%/yr
vs +9.6%/yr prior
5Y CAGR
-11.8%/yr
Recent acceleration
Acceleration
-16.3pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.17M | -8.1% |
| 2024 | $16.50M | +18.6% |
| 2023 | $13.91M | -25.6% |
| 2022 | $18.70M | -8.5% |
| 2021 | $20.43M | -28.3% |
| 2020 | $28.48M | +20.5% |
| 2019 | $23.64M | +82.5% |
| 2018 | $12.96M | +44.5% |
| 2017 | $8.96M | +38.8% |
| 2016 | $6.46M | - |